Bio-Techne Corp. planned insider sales
In the twelve months since 23 September 2025 insiders at Bio-Techne Corp. filed 2 Form 144 notices of planned sales, 8,612 shares worth $437,209 at the time of filing, from 1 seller. The latest, filed 8 May 2026: Joshua Molho (director), 6,636 shares worth $320,417, planned for around 8 May 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|
| 8 May 2026 | Joshua Molho | Director | 6,636 | $320,417 | 8 May 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of options under a registered plan | Form 144 |
| 17 February 2026 | Joshua Molho | Director | 1,976 | $116,791 | 17 February 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Previously Exercised Options | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was. Value is the filer's own aggregate market value. Whether the sale happened shows up later on Form 4, on the insiders page.
Source
Form 144 filings on EDGAR for Bio-Techne Corp.: the company's filing index, each notice read from its own XML.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.